quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 22, 2026

The Zacks Analyst Blog The Goldman Sachs, NextEra, Shopify, Landmark and ImmuCell

View original at nasdaq.com
The Zacks Analyst Blog The Goldman Sachs, NextEra, Shopify, Landmark and ImmuCell For Immediate Releases Chicago, IL – April 22, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Florida's improving economy is generating demand and boosting FPL's customer base

    60% confidence
  • Goldman Sachs rising expense base might hamper the company's near-term profitability

    60% confidence
  • Risks in operating nuclear power-based generation units, unfavorable weather conditions and increasing supply costs can adversely impact NextEra Energy earnings

    60% confidence
  • NextEra Energy will add more renewable projects to its portfolio and has nearly 29.8 GW of renewable projects in the backlog

    60% confidence
  • Shopify's expanding international footprint with strong growth in Europe is a key catalyst

    60% confidence
  • Shopify's investment in AI-driven tools is helping merchants improve customer engagement and streamline operations

    60% confidence
  • Goldman Sachs high dependence on overseas revenues is worrisome

    60% confidence
  • Goldman Sachs is narrowing the consumer footprint and prioritizing durable revenue streams across banking, markets and alternatives

    60% confidence
  • Since 2000, top stock-picking strategies have blown away the S&P's +7.7% average gain per year with average gains of +48.4%, +50.2% and +56.7% per year

    60% confidence
  • Goldman Sachs earnings beat estimates in each of the four trailing quarters

    60% confidence
  • Goldman Sachs solid liquidity profile will support its capital distribution activities

    60% confidence
  • Landmark Bancorp presents a compelling regional banking story, supported by a diversified lending franchise across residential, commercial and agricultural segments

    60% confidence
  • Goldman Sachs expansion in the private equity credit market is expected to diversify its revenue base and support its growth over the long run

    60% confidence
  • NextEra Energy's robust renewable backlog indicates strong earnings in the long-term

    60% confidence
  • ImmuCell has a differentiated, market-leading product in calf scours prevention that continues to gain share due to its consistent efficacy versus traditional alternatives

    60% confidence
  • Shopify faces gross margin pressure due to higher hosting costs, the three-month paid trial program, and the expanded PayPal partnership, which carries lower margins

    60% confidence
  • Shopify's prospects are benefiting from an expanding merchant base

    60% confidence

Data points we hold from this source

S&P 500 · average annual return7.7 percent
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
The Zacks Analyst Blog The Goldman Sachs, NextEra, Shopify, Landmark and ImmuCell — Source | Via News | pt.VIA.NEWS